Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders, 20605-20606 [2023-07191]
Download as PDF
Federal Register / Vol. 88, No. 66 / Thursday, April 6, 2023 / Notices
Issued in Washington, DC.
Jeffrey U. Vincent,
Executive Director, UAS Integration Office,
Federal Aviation Administration.
please call (202) 366–9317 or (202) 366–
9826 before visiting Dockets Operations.
[FR Doc. 2023–07226 Filed 4–5–23; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2023–0031]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders
Federal Motor Carrier Safety
Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of denials.
AGENCY:
FMCSA announces its
decision to deny applications from 132
individuals who requested an
exemption from the Federal Motor
Carrier Safety Regulations (FMCSRs)
prohibiting persons with a clinical
diagnosis of epilepsy or any other
condition that is likely to cause a loss
of consciousness or any loss of ability to
operate a commercial motor vehicle
(CMV) from operating CMVs in
interstate commerce.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Chief, Medical
Programs Division, FMCSA, Department
of Transportation, 1200 New Jersey
Avenue SE, Room W64–224,
Washington, DC 20590–0001, (202) 366–
4001, fmcsamedical@dot.gov. Office
hours are from 8:30 a.m. to 5 p.m. ET
Monday through Friday, except Federal
holidays. If you have questions
regarding viewing material in the
docket, contact Dockets Operations,
(202) 366–9826.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Public Participation
ddrumheller on DSK120RN23PROD with NOTICES1
A. Comments
To view comments go to
www.regulations.gov. Insert the docket
number (FMCSA–2023–0031) in the
keyword box, and click ‘‘Search.’’ Next,
sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed,
and click ‘‘Browse Comments.’’ If you
do not have access to the internet, you
may view the docket online by visiting
Dockets Operations in Room W12–140
on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE,
Washington, DC 20590–0001, between 9
a.m. and 5 p.m. ET Monday through
Friday, except Federal holidays. To be
sure someone is there to help you,
VerDate Sep<11>2014
21:13 Apr 05, 2023
Jkt 259001
B. Privacy Act
In accordance with 49 U.S.C.
31315(b)(6), DOT solicits comments
from the public on the exemption
request. DOT posts these comments,
without edit, including any personal
information the commenter provides, to
www.regulations.gov. As described in
the system of records notice DOT/ALL
14 (Federal Docket Management
System), which can be reviewed at
https://www.transportation.gov/
individuals/privacy/privacy-act-systemrecords-notices, the comments are
searchable by the name of the submitter.
II. Background
FMCSA received applications from
132 individuals who requested an
exemption from the FMCSRs
prohibiting persons with a clinical
diagnosis of epilepsy or any other
condition that is likely to cause a loss
of consciousness or any loss of ability to
operate a CMV from operating CMVs in
interstate commerce.
FMCSA has evaluated the eligibility
of these applicants and concluded that
granting these exemptions would not
provide a level of safety that would be
equivalent to, or greater than, the level
of safety that would be obtained by
complying with § 391.41(b)(8).
III. Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and
31315(b), FMCSA may grant an
exemption from the FMCSRs for no
longer than a 5-year period if it finds
such exemption would likely achieve a
level of safety that is equivalent to, or
greater than, the level that would be
achieved absent such exemption. The
statute also allows the Agency to renew
exemptions at the end of the 5-year
period. FMCSA grants medical
exemptions from the FMCSRs for a 2year period to align with the maximum
duration of a driver’s medical
certification. The Agency’s decision
regarding these exemption applications
is based on the eligibility criteria, the
terms and conditions for Federal
exemptions, and an individualized
assessment of each applicant’s medical
information provided by the applicant.
IV. Conclusion
The Agency has determined that these
applicants do not satisfy the eligibility
criteria or meet the terms and
conditions of the Federal exemption and
granting these exemptions would not
provide a level of safety that would be
equivalent to, or greater than, the level
of safety that would be obtained by
PO 00000
Frm 00140
Fmt 4703
Sfmt 4703
20605
complying with § 391.41(b)(8).
Therefore, the 132 applicants in this
notice have been denied exemptions
from the physical qualification
standards in § 391.41(b)(8).
Each applicant has, prior to this
notice, received a letter of final
disposition regarding his/her exemption
request. Those decision letters fully
outlined the basis for the denial and
constitute final action by the Agency.
This notice summarizes the Agency’s
recent denials as required under 49
U.S.C. 31315(b)(4) by periodically
publishing names and reasons for
denial.
The following 132 applicants do not
meet the minimum time requirement for
being seizure-free, either on or off of
anti-seizure medication:
Gary Abels (MN)
Zachary Adams (MS)
William Allen (MI)
Evan Bailey (CA)
Sherman Ballard (FL)
Eduardo Barboza (CA)
Michael Bartelt (WI)
Mark Bartlebaugh (TN)
Austin Baze (CA)
Duncan Bennett (TN)
Blake Bloddington (KS)
Gary Bohl (WY)
Alber Brown (GA)
Kenneth Brown (IN)
Dwight Bryson (VA)
Steven Bucklin (IL)
Rashawn Buggs (OH)
Walter Burks (MS)
Todd Burrey (OH)
Galen Butcher (WA)
Lydia Capelle (WY)
Pietro Capobianco (NJ)
Robert Carels (PA)
William Carol III (MD)
Perry Chase (VT)
Michael Curtin (NY)
Charles Curtis (NC)
Wade Davis (NC)
Jean Daza (NJ)
Aristedes Debarros (RI)
Michael Di Leonard (NY)
Joseph S. Drion (MO)
Gregory Durmaz (WA)
Kenneth Eife (NJ)
John Engle (IN)
Natalia Ericson (CA)
Marie Evans (TX)
Tray Freeman (NC)
Logan Fry (WA)
Drew Gettel (CO)
Timothy Gilroy (IA)
Chandler Gneiting (ID)
Dakota Graham (ID)
Anthony Gray (GA)
Charlotte Greek (CA)
Denise Gristi (CA)
Mario Gutierrez (CO)
Elton Hardin (IN)
E:\FR\FM\06APN1.SGM
06APN1
ddrumheller on DSK120RN23PROD with NOTICES1
20606
Federal Register / Vol. 88, No. 66 / Thursday, April 6, 2023 / Notices
Zachary Harkcom (PA)
Eric Harmon (MD)
Victor Haugen (NC)
Alexander Heckler (GA)
Christopher Hensel (MN)
Patricia Herman (CT)
Zachary Hewitt (PA)
Michael Holden (FL)
Barry Huan (TN)
Christine Jacks (AL)
Shaheed Jackson (GA)
Raymond Jackson (IL)
Richard Jeromchek (WA)
Preston Keim (IN)
Leonard King (NC)
Brandon Koole (MI)
Scotty Kuester (GA)
Jeffery Kueter (IA)
Bradley Kurtz (VA)
Sara Lockhart (MO)
Shane Lore (NJ)
Demon Lowe (NC)
Gabriella Lugtu (CA)
Blake Mallet (MA)
Douglas Mallon (NH)
Cole Martin (NC)
Matthew May (CT)
Taylor McBride (VA)
Nakia McCormick (NY)
Joseph Miller (IA)
Justin Moeller (IA)
Daniel Motisi (CO)
Brandon Muarry (IN)
Cole Neard (MT)
Glen Nelle (AR)
James Nicklasson (NE)
Sarah Ogle (IN)
Louis Orenstein (CO)
David Overhoff (NY)
Todd Paiano (NJ)
Richard Parsons (KS)
Tony Pearl (TN)
Robert Pinkston (NC)
Laci Poffenberger (MR)
Blake Quilia (VT)
Anthony Raasch (MI)
Donald Richard (VT)
Kevin Riggenbach (OH)
Clinton Rogers (MA)
Jay Rohde (MN)
Eric Rosello (DE)
Bryson Rowley (UT)
Ernest Sang (NC)
William Saucier (MN)
William Schaap (NJ)
Jason Shaw (IN)
Michael Shea (NJ)
Chad Shelhart (AZ)
Daryl Shupp (PA)
Michael Sifford (ID)
Paritpal Singh (CA)
Randall Slavik (MO)
Zachary Smith (IL)
Wesley Smith (UT)
Jeffrey Smith Jr. (FL)
Tammy Snyder (NC)
Lucas Sorey (NC)
Timothy Stassel (MO)
Christopher Strawbridge (WI)
VerDate Sep<11>2014
21:13 Apr 05, 2023
Jkt 259001
I. Public Participation
Joshua Thomason (SC)
Sean Treacy (PA)
Darby Tyler (WA)
Dimitra Tzortzis (GA)
Glenn Utter (AZ)
Paul Warren (ME)
Ryan Welder (PA)
Michael Weymouth (NH)
Cade Whitaker (ID)
George Wihoit (PA)
Steven Willett (MA)
Garrett Williams (CA)
James Wilson (TN)
Richard Wisor (PA)
Christian Yesbeck (VA)
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2023–07191 Filed 4–5–23; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2023–0041]
Qualification of Drivers; Exemption
Applications; Implantable Cardioverter
Defibrillator (ICD)
Federal Motor Carrier Safety
Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of denials.
AGENCY:
FMCSA announces its
decision to deny the applications from
four individuals treated with an
Implantable Cardioverter Defibrillator
(ICD) who requested an exemption from
the Federal Motor Carrier Safety
Regulations (FMCSRs) prohibiting
operation of a commercial motor vehicle
(CMV) in interstate commerce by
persons with a current clinical diagnosis
of myocardial infarction, angina
pectoris, coronary insufficiency,
thrombosis, or any other cardiovascular
disease of a variety known to be
accompanied by syncope (transient loss
of consciousness), dyspnea (shortness of
breath), collapse, or congestive heart
failure.
SUMMARY:
Ms.
Christine A. Hydock, Chief, Medical
Programs Division, FMCSA, DOT, 1200
New Jersey Avenue SE, Room W64–224,
Washington, DC 20590–0001, (202) 366–
4001, fmcsamedical@dot.gov. Office
hours are from 8:30 a.m. to 5 p.m. ET
Monday through Friday, except Federal
holidays. If you have questions
regarding viewing materials in the
docket, contact Dockets Operations,
(202) 366–9826.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00141
Fmt 4703
Sfmt 4703
A. Viewing Comments
To view comments go to
www.regulations.gov. Insert the docket
number (FMCSA–2023–0041) in the
keyword box and click ‘‘Search.’’ Next,
sort the results by ‘‘Posted (NewerOlder),’’ choose the first notice listed,
and click ‘‘Browse Comments.’’ If you
do not have access to the internet, you
may view the docket online by visiting
Dockets Operations in Room W12–140
on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE,
Washington, DC 20590–0001, between 9
a.m. and 5 p.m. ET Monday through
Friday, except Federal holidays. To be
sure someone is there to help you,
please call (202) 366–9317 or (202) 366–
9826 before visiting Dockets Operations.
B. Privacy Act
In accordance with 49 U.S.C.
31315(b)(6), DOT solicits comments
from the public on the exemption
requests. DOT posts these comments,
without edit, including any personal
information the commenter provides, to
www.regulations.gov. As described in
the system of records notice DOT/ALL
14 (Federal Docket Management
System), which can be reviewed at
https://www.transportation.gov/
individuals/privacy/privacy-act-systemrecords-notices, the comments are
searchable by the name of the submitter.
II. Background
On February 13, 2023, FMCSA
published a notice announcing receipt
of applications from four individuals
treated with ICDs and requested
comments from the public (88 FR 9318).
The individuals requested an exemption
from 49 CFR 391.41(b)(4) which
prohibits operation of a CMV in
interstate commerce by persons with a
current clinical diagnosis of myocardial
infarction, angina pectoris, coronary
insufficiency, thrombosis, or any other
cardiovascular disease of a variety
known to be accompanied by syncope,
dyspnea, collapse, or congestive heart
failure. The public comment period
ended on March 15, 2023, and one
comment was received.
FMCSA has evaluated the eligibility
of the applicants and concluded that
granting an exemption would not
provide a level of safety that would be
equivalent to, or greater than, the level
of safety that would be obtained by
complying with § 391.41(b)(4). A
summary of each applicant’s medical
history related to their ICD exemption
request was discussed in the February
13, 2023, Federal Register notice (88 FR
9318), and will not be repeated here.
E:\FR\FM\06APN1.SGM
06APN1
Agencies
[Federal Register Volume 88, Number 66 (Thursday, April 6, 2023)]
[Notices]
[Pages 20605-20606]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07191]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2023-0031]
Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of denials.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to deny applications from 132
individuals who requested an exemption from the Federal Motor Carrier
Safety Regulations (FMCSRs) prohibiting persons with a clinical
diagnosis of epilepsy or any other condition that is likely to cause a
loss of consciousness or any loss of ability to operate a commercial
motor vehicle (CMV) from operating CMVs in interstate commerce.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, FMCSA, Department of Transportation, 1200
New Jersey Avenue SE, Room W64-224, Washington, DC 20590-0001, (202)
366-4001, [email protected]. Office hours are from 8:30 a.m. to 5
p.m. ET Monday through Friday, except Federal holidays. If you have
questions regarding viewing material in the docket, contact Dockets
Operations, (202) 366-9826.
SUPPLEMENTARY INFORMATION:
I. Public Participation
A. Comments
To view comments go to www.regulations.gov. Insert the docket
number (FMCSA-2023-0031) in the keyword box, and click ``Search.''
Next, sort the results by ``Posted (Newer-Older),'' choose the first
notice listed, and click ``Browse Comments.'' If you do not have access
to the internet, you may view the docket online by visiting Dockets
Operations in Room W12-140 on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE, Washington, DC 20590-0001, between
9 a.m. and 5 p.m. ET Monday through Friday, except Federal holidays. To
be sure someone is there to help you, please call (202) 366-9317 or
(202) 366-9826 before visiting Dockets Operations.
B. Privacy Act
In accordance with 49 U.S.C. 31315(b)(6), DOT solicits comments
from the public on the exemption request. DOT posts these comments,
without edit, including any personal information the commenter
provides, to www.regulations.gov. As described in the system of records
notice DOT/ALL 14 (Federal Docket Management System), which can be
reviewed at https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices, the comments are searchable by the name of
the submitter.
II. Background
FMCSA received applications from 132 individuals who requested an
exemption from the FMCSRs prohibiting persons with a clinical diagnosis
of epilepsy or any other condition that is likely to cause a loss of
consciousness or any loss of ability to operate a CMV from operating
CMVs in interstate commerce.
FMCSA has evaluated the eligibility of these applicants and
concluded that granting these exemptions would not provide a level of
safety that would be equivalent to, or greater than, the level of
safety that would be obtained by complying with Sec. 391.41(b)(8).
III. Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption
from the FMCSRs for no longer than a 5-year period if it finds such
exemption would likely achieve a level of safety that is equivalent to,
or greater than, the level that would be achieved absent such
exemption. The statute also allows the Agency to renew exemptions at
the end of the 5-year period. FMCSA grants medical exemptions from the
FMCSRs for a 2-year period to align with the maximum duration of a
driver's medical certification. The Agency's decision regarding these
exemption applications is based on the eligibility criteria, the terms
and conditions for Federal exemptions, and an individualized assessment
of each applicant's medical information provided by the applicant.
IV. Conclusion
The Agency has determined that these applicants do not satisfy the
eligibility criteria or meet the terms and conditions of the Federal
exemption and granting these exemptions would not provide a level of
safety that would be equivalent to, or greater than, the level of
safety that would be obtained by complying with Sec. 391.41(b)(8).
Therefore, the 132 applicants in this notice have been denied
exemptions from the physical qualification standards in Sec.
391.41(b)(8).
Each applicant has, prior to this notice, received a letter of
final disposition regarding his/her exemption request. Those decision
letters fully outlined the basis for the denial and constitute final
action by the Agency. This notice summarizes the Agency's recent
denials as required under 49 U.S.C. 31315(b)(4) by periodically
publishing names and reasons for denial.
The following 132 applicants do not meet the minimum time
requirement for being seizure-free, either on or off of anti-seizure
medication:
Gary Abels (MN)
Zachary Adams (MS)
William Allen (MI)
Evan Bailey (CA)
Sherman Ballard (FL)
Eduardo Barboza (CA)
Michael Bartelt (WI)
Mark Bartlebaugh (TN)
Austin Baze (CA)
Duncan Bennett (TN)
Blake Bloddington (KS)
Gary Bohl (WY)
Alber Brown (GA)
Kenneth Brown (IN)
Dwight Bryson (VA)
Steven Bucklin (IL)
Rashawn Buggs (OH)
Walter Burks (MS)
Todd Burrey (OH)
Galen Butcher (WA)
Lydia Capelle (WY)
Pietro Capobianco (NJ)
Robert Carels (PA)
William Carol III (MD)
Perry Chase (VT)
Michael Curtin (NY)
Charles Curtis (NC)
Wade Davis (NC)
Jean Daza (NJ)
Aristedes Debarros (RI)
Michael Di Leonard (NY)
Joseph S. Drion (MO)
Gregory Durmaz (WA)
Kenneth Eife (NJ)
John Engle (IN)
Natalia Ericson (CA)
Marie Evans (TX)
Tray Freeman (NC)
Logan Fry (WA)
Drew Gettel (CO)
Timothy Gilroy (IA)
Chandler Gneiting (ID)
Dakota Graham (ID)
Anthony Gray (GA)
Charlotte Greek (CA)
Denise Gristi (CA)
Mario Gutierrez (CO)
Elton Hardin (IN)
[[Page 20606]]
Zachary Harkcom (PA)
Eric Harmon (MD)
Victor Haugen (NC)
Alexander Heckler (GA)
Christopher Hensel (MN)
Patricia Herman (CT)
Zachary Hewitt (PA)
Michael Holden (FL)
Barry Huan (TN)
Christine Jacks (AL)
Shaheed Jackson (GA)
Raymond Jackson (IL)
Richard Jeromchek (WA)
Preston Keim (IN)
Leonard King (NC)
Brandon Koole (MI)
Scotty Kuester (GA)
Jeffery Kueter (IA)
Bradley Kurtz (VA)
Sara Lockhart (MO)
Shane Lore (NJ)
Demon Lowe (NC)
Gabriella Lugtu (CA)
Blake Mallet (MA)
Douglas Mallon (NH)
Cole Martin (NC)
Matthew May (CT)
Taylor McBride (VA)
Nakia McCormick (NY)
Joseph Miller (IA)
Justin Moeller (IA)
Daniel Motisi (CO)
Brandon Muarry (IN)
Cole Neard (MT)
Glen Nelle (AR)
James Nicklasson (NE)
Sarah Ogle (IN)
Louis Orenstein (CO)
David Overhoff (NY)
Todd Paiano (NJ)
Richard Parsons (KS)
Tony Pearl (TN)
Robert Pinkston (NC)
Laci Poffenberger (MR)
Blake Quilia (VT)
Anthony Raasch (MI)
Donald Richard (VT)
Kevin Riggenbach (OH)
Clinton Rogers (MA)
Jay Rohde (MN)
Eric Rosello (DE)
Bryson Rowley (UT)
Ernest Sang (NC)
William Saucier (MN)
William Schaap (NJ)
Jason Shaw (IN)
Michael Shea (NJ)
Chad Shelhart (AZ)
Daryl Shupp (PA)
Michael Sifford (ID)
Paritpal Singh (CA)
Randall Slavik (MO)
Zachary Smith (IL)
Wesley Smith (UT)
Jeffrey Smith Jr. (FL)
Tammy Snyder (NC)
Lucas Sorey (NC)
Timothy Stassel (MO)
Christopher Strawbridge (WI)
Joshua Thomason (SC)
Sean Treacy (PA)
Darby Tyler (WA)
Dimitra Tzortzis (GA)
Glenn Utter (AZ)
Paul Warren (ME)
Ryan Welder (PA)
Michael Weymouth (NH)
Cade Whitaker (ID)
George Wihoit (PA)
Steven Willett (MA)
Garrett Williams (CA)
James Wilson (TN)
Richard Wisor (PA)
Christian Yesbeck (VA)
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2023-07191 Filed 4-5-23; 8:45 am]
BILLING CODE 4910-EX-P